BIO CEO and Investor Conference in New York, NY
February 12 - February 13, 2018
Presentation Time: February 12, 2018 at 10:30am
Cowen and Company Annual Healthcare Conference in Boston, MA
March 12 – March 14, 2018
Presentation Time: March 12, 2018 at 2:30pm
Oppenheimer Annual Healthcare Conference in New York, NY
March 20 – March 21, 2018
Presentation Time: March 21, 2018 at 8:35am
"We are thrilled to have the opportunity to present SQZ's vision of developing a new generation of cell-based therapies," remarked Armon Sharei, PhD, CEO at SQZ. "It is an honor to be selected as a private company and we look forward to discussing our potential to implement previously inaccessible therapies across multiple disease areas."
About SQZ Biotech SQZ Biotechnologies is a Massachusetts-based, privately held company developing cellular therapies for multiple indications using the proprietary CellSqueeze® technology. Through internal research programs and external partnerships, SQZ's unique cell engineering capabilities are being used to develop a new generation of cell therapies to address a wide range of clinical challenges. For more information please visit www.sqzbiotech.com.
SQZ Contact: Rebecca Cohen
Manager, Corporate Relations & Administration [email protected] 617-758-8672 ext. 728
SQZ Media Contact: Justin Jackson
Burns McClellan 212-213-0006, ext. 327 [email protected]
View original content:http://www.prnewswire.com/news-releases/sqz-biotech-to-present-at-investor-conferences-in-first-quarter-2018-300593144.html
SOURCE SQZ Biotechnologies
